Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - HOOKIPA Pharma Inc. | hook-20210331x10q.htm |
| EX-31.2 - EX-31.2 - HOOKIPA Pharma Inc. | hook-20210331ex3127084e0.htm |
| EX-31.1 - EX-31.1 - HOOKIPA Pharma Inc. | hook-20210331ex311a25a44.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of HOOKIPA Pharma Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, hereby certify, that to the best of their knowledge:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: May 12, 2021 | /s/ Joern Aldag |
| |
| Joern Aldag |
| Chief Executive Officer |
| (Principal Executive Officer) |
| |
Dated: May 12, 2021 | /s/ Reinhard Kandera |
| |
| Reinhard Kandera |
| Chief Financial Officer |
| (Principal Financial Officer) |